Published in J Med Genet on January 01, 2004
The unfolded protein response and its relevance to connective tissue diseases. Cell Tissue Res (2009) 1.20
Altered integration of matrilin-3 into cartilage extracellular matrix in the absence of collagen IX. Mol Cell Biol (2005) 1.19
Decreased chondrocyte proliferation and dysregulated apoptosis in the cartilage growth plate are key features of a murine model of epiphyseal dysplasia caused by a matn3 mutation. Hum Mol Genet (2007) 1.18
COMP mutation screening as an aid for the clinical diagnosis and counselling of patients with a suspected diagnosis of pseudoachondroplasia or multiple epiphyseal dysplasia. Eur J Hum Genet (2005) 1.13
Analysing the role of endogenous matrix molecules in the development of osteoarthritis. Int J Exp Pathol (2009) 1.13
Multiple epiphyseal dysplasia mutations in MATN3 cause misfolding of the A-domain and prevent secretion of mutant matrilin-3. Hum Mutat (2005) 1.12
Functional knockout of the matrilin-3 gene causes premature chondrocyte maturation to hypertrophy and increases bone mineral density and osteoarthritis. Am J Pathol (2006) 1.11
Unique matrix structure in the rough endoplasmic reticulum cisternae of pseudoachondroplasia chondrocytes. Am J Pathol (2007) 1.03
An unfolded protein response is the initial cellular response to the expression of mutant matrilin-3 in a mouse model of multiple epiphyseal dysplasia. Cell Stress Chaperones (2010) 1.03
Association of matrilin-3 polymorphisms with spinal disc degeneration and osteoarthritis of the first carpometacarpal joint of the hand. Ann Rheum Dis (2006) 0.96
Structural and functional characterization of recombinant matrilin-3 A-domain and implications for human genetic bone diseases. J Biol Chem (2007) 0.96
An inducible cartilage oligomeric matrix protein mouse model recapitulates human pseudoachondroplasia phenotype. Am J Pathol (2009) 0.94
Type IX collagen gene mutations can result in multiple epiphyseal dysplasia that is associated with osteochondritis dissecans and a mild myopathy. Am J Med Genet A (2010) 0.92
Genotype to phenotype correlations in cartilage oligomeric matrix protein associated chondrodysplasias. Eur J Hum Genet (2014) 0.87
Preselection of cases through expert clinical and radiological review significantly increases mutation detection rate in multiple epiphyseal dysplasia. Eur J Hum Genet (2006) 0.87
Armet/Manf and Creld2 are components of a specialized ER stress response provoked by inappropriate formation of disulphide bonds: implications for genetic skeletal diseases. Hum Mol Genet (2013) 0.84
Matrilin-3 inhibits chondrocyte hypertrophy as a bone morphogenetic protein-2 antagonist. J Biol Chem (2014) 0.82
Multiple functions of the von Willebrand Factor A domain in matrilins: secretion, assembly, and proteolysis. J Orthop Surg Res (2008) 0.82
Matrilin-3 chondrodysplasia mutations cause attenuated chondrogenesis, premature hypertrophy and aberrant response to TGF-β in chondroprogenitor cells. Int J Mol Sci (2014) 0.80
The utility of mouse models to provide information regarding the pathomolecular mechanisms in human genetic skeletal diseases: The emerging role of endoplasmic reticulum stress (Review). Int J Mol Med (2015) 0.79
Loss of matrilin 1 does not exacerbate the skeletal phenotype in a mouse model of multiple epiphyseal dysplasia caused by a Matn3 V194D mutation. Arthritis Rheum (2012) 0.78
Matrilin-2 is a widely distributed extracellular matrix protein and a potential biomarker in the early stage of osteoarthritis in articular cartilage. Biomed Res Int (2014) 0.76
Mild myopathy is associated with COMP but not MATN3 mutations in mouse models of genetic skeletal diseases. PLoS One (2013) 0.76
Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell (1997) 7.47
Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med (1996) 7.26
From meaning to term: semantic locality in the UMLS Metathesaurus. Proc Annu Symp Comput Appl Med Care (1991) 4.59
Cystic fibrosis carrier testing in early pregnancy by general practitioners. BMJ (1993) 3.85
Navigating to knowledge. Methods Inf Med (1995) 3.69
One thousand health-related quality-of-life estimates. Med Care (2000) 3.53
Metaphrase: an aid to the clinical conceptualization and formalization of patient problems in healthcare enterprises. Methods Inf Med (1998) 3.24
Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language System. Proc AMIA Annu Fall Symp (1997) 2.93
Merging terminologies. Medinfo (1995) 2.91
Mutations in the RNA component of RNase MRP cause a pleiotropic human disease, cartilage-hair hypoplasia. Cell (2001) 2.86
Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet (1995) 2.55
The heritability of general cognitive ability increases linearly from childhood to young adulthood. Mol Psychiatry (2009) 2.52
Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells. J Immunol (1998) 2.49
The molecular genetics of Marfan syndrome and related disorders. J Med Genet (2006) 2.45
Constitutively activated receptors for parathyroid hormone and parathyroid hormone-related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med (1996) 2.30
Identification of a novel common genetic risk factor for lumbar disk disease. JAMA (2001) 2.28
Stop codon in the procollagen II gene (COL2A1) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci U S A (1991) 2.24
BRAF mutation testing algorithm for vemurafenib treatment in melanoma: recommendations from an expert panel. Br J Dermatol (2013) 2.17
Cystic fibrosis carrier screening at first diagnosis of pregnancy in general practice. Lancet (1992) 2.16
Test liquids for quantitative MRI measurements of self-diffusion coefficient in vivo. Magn Reson Med (2000) 2.14
Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A (1998) 2.14
MEME-II supports the cooperative management of terminology. Proc AMIA Annu Fall Symp (1996) 2.06
Abnormal type I collagen metabolism by cultured fibroblasts in lethal perinatal osteogenesis imperfecta. Biochem J (1984) 1.98
Formal properties of the Metathesaurus. Proc Annu Symp Comput Appl Med Care (1994) 1.97
Meta-analysis of genome-wide association studies for personality. Mol Psychiatry (2010) 1.96
Disruption of phagosomal membranes of normal alveolar macrophages by the H37Rv strain of Mycobacterium tuberculosis. A correlate of virulence. Am Rev Respir Dis (1984) 1.93
Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet (1999) 1.88
Molecular characterisation of SMARCB1 and NF2 in familial and sporadic schwannomatosis. J Med Genet (2008) 1.87
An allele of COL9A2 associated with intervertebral disc disease. Science (1999) 1.85
Do physicians do as they say? The case of mammography. Arch Fam Med (1997) 1.85
Field comparison of the interferon-gamma assay and the intradermal tuberculin test for the diagnosis of bovine tuberculosis. Aust Vet J (1991) 1.82
Maternal vitamin D status determines bone variables in the newborn. J Clin Endocrinol Metab (2010) 1.80
Mutations in cartilage oligomeric matrix protein causing pseudoachondroplasia and multiple epiphyseal dysplasia affect binding of calcium and collagen I, II, and IX. J Biol Chem (2000) 1.79
Cerebral palsy and socioeconomic status: a retrospective cohort study. Arch Dis Child (2005) 1.77
Genetic structure of spatial and verbal working memory. Behav Genet (2001) 1.69
Reliability of radiological measurements in the assessment of the child's hip. J Bone Joint Surg Br (1989) 1.66
Mutations in the region encoding the von Willebrand factor A domain of matrilin-3 are associated with multiple epiphyseal dysplasia. Nat Genet (2001) 1.64
Cartilage oligomeric matrix protein interacts with type IX collagen, and disruptions to these interactions identify a pathogenetic mechanism in a bone dysplasia family. J Biol Chem (2000) 1.63
Collagen defects in lethal perinatal osteogenesis imperfecta. Biochem J (1986) 1.62
Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study. BJU Int (2010) 1.60
Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments. FEBS Lett (1998) 1.55
Lethal perinatal osteogenesis imperfecta due to the substitution of arginine for glycine at residue 391 of the alpha 1(I) chain of type I collagen. J Biol Chem (1987) 1.54
Accident Prevention. Am J Public Health Nations Health (1946) 1.50
Validation of preferences for life-sustaining treatment: implications for advance care planning. Ann Intern Med (1997) 1.50
Exon 10b of the NF1 gene represents a mutational hotspot and harbors a recurrent missense mutation Y489C associated with aberrant splicing. Genet Med (2001) 1.50
Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet (1998) 1.49
Plants genetically modified to produce N-acylhomoserine lactones communicate with bacteria. Nat Biotechnol (1999) 1.48
Hydrocortisone-induced inhibition of reactive oxygen species by polymorphonuclear neutrophils. Crit Care Med (1999) 1.47
Human G(olf) gene polymorphisms and vulnerability to bipolar disorder. Psychiatr Genet (1998) 1.47
Genotype/phenotype correlations in type 2 neurofibromatosis (NF2): evidence for more severe disease associated with truncating mutations. J Med Genet (1998) 1.47
High-resolution linkage-disequilibrium mapping of the cartilage-hair hypoplasia gene. Am J Hum Genet (1994) 1.45
Screening for congenital dislocation of the hip in Australia. J Paediatr Child Health (1991) 1.45
Phylogenetic network of the mtDNA haplogroup U in Northern Finland based on sequence analysis of the complete coding region by conformation-sensitive gel electrophoresis. Am J Hum Genet (2000) 1.45
Receptive field organization of 'sustained' and 'transient' retinal ganglion cells which subserve different function roles. J Physiol (1972) 1.45
Confusing serological abnormalities in bird fancier's lung. BMJ (1990) 1.43
The tensor distribution function. Magn Reson Med (2009) 1.43
Corneal collagen fibril structure in three dimensions: Structural insights into fibril assembly, mechanical properties, and tissue organization. Proc Natl Acad Sci U S A (2001) 1.43
Characterization of point mutations in the collagen COL1A1 and COL1A2 genes causing lethal perinatal osteogenesis imperfecta. J Biol Chem (1989) 1.42
Deletion of 24 amino acids from the pro-alpha 1(I) chain of type I procollagen in a patient with the Ehlers-Danlos syndrome type VII. J Biol Chem (1986) 1.41
Comment on 'A systematic review of the precision and accuracy of dose measurements in photon radiotherapy using polymer and fricke MRI gel dosimetry'. Phys Med Biol (2003) 1.40
Effects of Iron and Chelating Agents on Dark Carboxylation Reactions in Plant Homogenates. Plant Physiol (1959) 1.39
Mutation analysis of core binding factor A1 in patients with cleidocranial dysplasia. Am J Hum Genet (1999) 1.39
Submicroscopic subtelomeric 1qter deletions: a recognisable phenotype? J Med Genet (2001) 1.38
Expression of a partially deleted gene of human type II procollagen (COL2A1) in transgenic mice produces a chondrodysplasia. Proc Natl Acad Sci U S A (1991) 1.38
Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease. FEBS Lett (1998) 1.35
A frameshift mutation results in a truncated nonfunctional carboxyl-terminal pro alpha 1(I) propeptide of type I collagen in osteogenesis imperfecta. J Biol Chem (1989) 1.34
A mutation in COL9A1 causes multiple epiphyseal dysplasia: further evidence for locus heterogeneity. Am J Hum Genet (2001) 1.33
Diverse mutations in the gene for cartilage oligomeric matrix protein in the pseudoachondroplasia-multiple epiphyseal dysplasia disease spectrum. Am J Hum Genet (1998) 1.33
First-stage autosomal genome screen in extended pedigrees suggests genes predisposing to low bone mineral density on chromosomes 1p, 2p and 4q. Eur J Hum Genet (1998) 1.32
Cartilage-hair hypoplasia gene assigned to chromosome 9 by linkage analysis. Nat Genet (1993) 1.30
Update on the Manchester Scoring System for BRCA1 and BRCA2 testing. J Med Genet (2005) 1.29
Skeletal phenotype in patients with Shwachman-Diamond syndrome and mutations in SBDS. Clin Genet (2004) 1.27
Incomplete healing of simple bone cysts after steroid injections. J Bone Joint Surg Br (1997) 1.27
Molecular genetics in the National Health Service in Britain. J Med Genet (1989) 1.27
A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study. J Urol (2000) 1.27
The uptake and acceptability to patients of cystic fibrosis carrier testing offered in pregnancy by the GP. J Med Genet (1997) 1.26
A splice-junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro alpha 1(V) chains results in the gravis form of the Ehlers-Danlos syndrome (type I). Hum Mol Genet (1996) 1.26
Autoantibodies to type II collagen: occurrence in rheumatoid arthritis, other arthritides, autoimmune connective tissue diseases, and chronic inflammatory syndromes. Ann Rheum Dis (1988) 1.26
Collagen composition of normal and myxomatous human mitral heart valves. Biochem J (1984) 1.25
Sequence variations in the collagen IX and XI genes are associated with degenerative lumbar spinal stenosis. Ann Rheum Dis (2003) 1.23
Maternal vitamin D status affects bone growth in early childhood--a prospective cohort study. Osteoporos Int (2010) 1.23
Three weeks of Kirschner wire fixation for displaced lateral condylar fractures of the humerus in children. J Pediatr Orthop (2001) 1.23
Characterization of an arginine 789 to cysteine substitution in alpha 1 (II) collagen chains of a patient with spondyloepiphyseal dysplasia. J Biol Chem (1993) 1.23
Substitution of arginine for glycine 664 in the collagen alpha 1(I) chain in lethal perinatal osteogenesis imperfecta. Demonstration of the peptide defect by in vitro expression of the mutant cDNA. J Biol Chem (1988) 1.21
Properties of LGN cells in kittens reared with convergent squint: a neurophysiological demonstration of amblyopia. Exp Brain Res (1976) 1.21
A study of the structure-activity relationship for diazaborine inhibition of Escherichia coli enoyl-ACP reductase. J Mol Biol (2001) 1.21
The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes. FASEB J (2000) 1.20
A homozygous stop codon in the lysyl hydroxylase gene in two siblings with Ehlers-Danlos syndrome type VI. Nat Genet (1992) 1.20
Mutations of the alpha2(V) chain of type V collagen impair matrix assembly and produce ehlers-danlos syndrome type I. Hum Mol Genet (1998) 1.19
Medial physeal stapling for primary and secondary genu valgum in late childhood and adolescence. J Bone Joint Surg Br (1995) 1.18
Treatment of acute osteomyelitis in childhood. J Bone Joint Surg Br (1982) 1.18
Barth syndrome: an X-linked cause of fetal cardiomyopathy and stillbirth. Prenat Diagn (2010) 1.17
COL9A3: A third locus for multiple epiphyseal dysplasia. Am J Hum Genet (1999) 1.17